The CDC Prevention Grant Funding Opportunity Announcement (FOA) and OA’s Response Overview and Discussion September 21, 2011 California Department of Public Health, Office of AIDS

 Introduction & Background  Structure for OA-funded activities:  Tier I and Tier II  Changes to HIV Prevention Programs  Allocations  Next Steps  Discussion and Q&A Agenda

New Direction in HIV Prevention  Identify people with HIV infection  Link to care, retain and reengage  Reduce viral load for individuals and the community

The CDC FOA A more prescriptive approach which emphasizes:  HIV testing  Prevention with positives and their partners  Services in medical settings  Structural and policy interventions  Increasing collaboration between prevention and care

Overview of OA’s Response

OA’s Design for Prevention Activities: Tier I and Tier II OA’s Tier I and Tier II activities reflect the priorities described in the FOA OA will take on some of these activities LHJs will be able to choose among Tier I activities (or implement all) LHJs may choose to implement Tier II activities when Tier I activities have all been met

Tier I Activities Testing Linkage to care Partner services Risk assessment, linkages to services and behavioral interventions for HIV+ people HIV treatment adherence Syringe services programs Policy initiatives – Surveillance data use – Leveraging SAMHSA HIV set- aside funds – Healthcare reform planning Condom distribution & syringe supply bank State community planning

Tier II - Activities Hepatitis C testing (can test in non-healthcare settings prior to fulfilling all Tier I activities) Integrated HIV, hepatitis, TB and STD screening Behavioral interventions for high-risk negative people Social marketing, media and mobilization Pre-exposure prophylaxis (PrEP) planning and/or delivery

All Tier I activities must be implemented before funding can be used for Tier II activities. Tier I activities may be funded with either OA funding or other funding. The Expanded Testing in Healthcare Settings funding, which had been a separate grant from the CDC, has been integrated into this CDC prevention grant as Category B. Details of the Tier Design

 HIV Test kits to funded CPA jurisdictions  CA AIDS Clearinghouse supplies to all CPG LHJs:  Condoms  Harm reduction materials and syringe supply bank  Educational materials  LEO is available for use by all LHJs OA Resources

Settings - more emphasis on healthcare settings for HIV positive people, and linkages Targets - more emphasis on HIV positive individuals and their partners Activities – even more emphasis on evidence- based interventions CDC Changes for Prevention Programs

Process for Program Implementation Fiscal implementation: January 1, 2012 Programmatic implementation: July 1, 2012 This provides a 6-month period to adjust prevention programs to new directions

Fiscal Implementation Application of allocation formula cannot be done until official award amount is provided. – CDC did not include a date awards will be announced. There will be more funds available for allocation to the funded LHJs. Models of possible award amounts have been developed. A draft was provided to CCLAD members. A supplemental grant award will be provided for January 1, 2012 through June 30, New award amounts will be used for FY

Allocation Funding Formula Previous formula New HIV infections identified through C&T (3 years) (20%) % Newly reported HIV cases (20%) % Living AIDS cases (20%) % Male syphilis (1 year) (7.5%) % Male gonorrhea (1 year) (7.5%) % Non-Hispanic AA (15%) % Hispanics (5%) % Below poverty level (5%) Current formula % People living with HIV and AIDS, excluding state prison cases (75%) % Non-Hispanic AA (15%) % Hispanics (5%) % Below poverty level (5%)

Activities between January 1 st and July 1 st may include: Maintaining some activities Concluding some activities Planning for some new activities OA has been granted transitional funding Transitional funding will assist programs requiring significant alteration as a result of the new grant direction. Transition Period

Timeline: Program-Specific Webinars October 13 th – Transitional Period October 20 th – Testing Activities October 27 th – PWP Activities November 3 rd – Policy Initiatives November 10 th – Syringe Service Programs & California AIDS Clearinghouse November 17 th – Tier II Activities (Social Marketing, HE/RR for High Risk Negatives, Hep C Testing, PrEP) December 8 th – Putting it All Together

To provide feedback on OA’s response to the FOA, please send comments to: